Depressive symptoms diagnosis and treatment of schizophrenia and schizophrenia spectrum disorders in Russian clinical practice

被引:0
|
作者
Gurovich, I. Ya [1 ]
Shmukler, A. B.
Storozhakova, Ya A.
Kiryanova, E. M.
Salnikova, L. I.
Gazha, A. K.
Maximova, N. E.
Stepanova, O. N.
Suchkov, Yu A.
机构
[1] Moscow Res Inst Psychiat, Moscow, Russia
关键词
depression; schizophrenia; schizophrenia spectrum disorders; antidepressants; SCHIZOAFFECTIVE DISORDER; IMIPRAMINE; ANTIDEPRESSANTS; SERTRALINE; THERAPY;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A cohort study of depression in schizophrenia and schizophrenia spectrum disorders was conducted in four Russian regional mental health services with the use of simultaneous one-day census on October 20, 2011. The total number of patients in this study was 1269: 753 patients were receiving outpatient treatment, 143 patients were served in day clinics and 373 patients were in-patients in psychiatric hospitals. Depressive symptoms were present in 6.0% of outpatients, 50.3% of day clinic patients, and 36.5% of inpatients. The average duration of current depressive symptoms in weeks was 10.0, 8.1, 9.0, respectively. The periods of depressive symptoms during the last 2 years were revealed in 30.8% of outpatients, 67.8% of day clinic patients, and 42.1% of inpatients with the average duration of each such period in weeks 10.9, 12.2, 8.3, respectively. In outpatient settings, 28.8% of patients received antidepressants in addition to antipsychotic therapy. The proportion of inpatients receiving this treatment was 42.1%, and two thirds of patients received antidepressants in day clinics.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 50 条
  • [31] Depressive and paradepressive symptoms clinical features in patients with schizophrenia
    Sincha, K. A.
    ZAPOROZHYE MEDICAL JOURNAL, 2016, (01) : 68 - 71
  • [32] A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders
    Guessoum, Selim Benjamin
    Le Strat, Yann
    Dubertret, Caroline
    Mallet, Jasmina
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2020, 99
  • [33] The efficacy of perospirone for the treatment of anxiety and depressive symptoms in schizophrenia
    Kikuyama, Hiroki
    Koh, Jun
    Okamura, Takehiko
    Yoneda, Hiroshi
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (04) : A21 - A21
  • [34] Venlafaxine in the treatment of resistant postpsychotic depressive symptoms of schizophrenia
    Mazeh, D
    Melamed, Y
    Elizur, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (03) : 284 - 285
  • [35] DEPRESSIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA
    MONTGOMERY, SM
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1979, 3 (04): : 429 - 433
  • [36] NEGATIVE AND DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIA
    KULHARA, P
    AVASTHI, A
    CHADDA, R
    CHANDIRAMANI, K
    MATTOO, SK
    KOTA, SK
    JOSEPH, S
    BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 : 207 - 211
  • [37] Depressive and basic symptoms in schizophrenia
    Maggini, C
    Raballo, A
    Salvatore, P
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2004, 11 (01) : 1 - 6
  • [38] Depressive symptoms in patients with schizophrenia
    Aladashvili, T.
    EUROPEAN PSYCHIATRY, 2016, 33 : S141 - S142
  • [39] Depressive symptoms in patients with schizophrenia
    Aladashvili, T.
    Tavadze, E.
    Gorgodze, Q.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S538 - S539
  • [40] Treatment adherence and insight in schizophrenia spectrum disorders
    Laabidi, S.
    Abidi, O.
    Aissa, A.
    Hosni, R.
    Ouali, U.
    Jomli, R.
    EUROPEAN PSYCHIATRY, 2024, 67 : S725 - S725